On Jan. 27, 2021, researchers at the Broad Institute of MIT and Harvard, and Massachusetts General Hospital’s Center for Genomic Medicine announced a clinical test that includes polygenic scores to estimate a patient’s risk for one of the world’s leading causes of death – heart attack.

The pilot test is a collaboration between Mass General and Color, a health technology company, which will run the test and generate results. The test is not yet covered by insurance and is available to any patient, including someone with a strong family history of heart disease.

Mass General’s new Preventive Genomics Clinic,began offering the test to patients in December, 2020.